PTCT Straddle Strategy
PTCT (PTC Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States, as well as to treat nonsense mutation Duchenne muscular dystrophy in Brazil and Russia; commercializes Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean; and markets Evrysdi for the treatment of spinal muscular atrophy in adults and children two months and older in Brazil. The company's splicing platform includes PTC518, which is being developed for the treatment of Huntington's disease. PTC Therapeutics, Inc. has collaborations with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., as well as the Spinal Muscular Atrophy Foundation to advance drug discovery and development research in regenerative medicine; and Akcea Therapeutics, Inc. to commercialize Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean.
PTCT (PTC Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $6.09B, a beta of 0.53 versus the broader market, a 52-week range of 43.175-87.5, average daily share volume of 1.3M, a public-listing history dating back to 2013, approximately 939 full-time employees. These structural characteristics shape how PTCT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.53 indicates PTCT has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a straddle on PTCT?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current PTCT snapshot
As of May 15, 2026, spot at $71.73, ATM IV 46.10%, IV rank 18.56%, expected move 13.22%. The straddle on PTCT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on PTCT specifically: PTCT IV at 46.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a PTCT straddle, with a market-implied 1-standard-deviation move of approximately 13.22% (roughly $9.48 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PTCT expiries trade a higher absolute premium for lower per-day decay. Position sizing on PTCT should anchor to the underlying notional of $71.73 per share and to the trader's directional view on PTCT stock.
PTCT straddle setup
The PTCT straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PTCT near $71.73, the first option leg uses a $71.73 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PTCT chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PTCT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $71.73 | N/A |
| Buy 1 | Put | $71.73 | N/A |
PTCT straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
PTCT straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on PTCT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on PTCT
Straddles on PTCT are pure-volatility plays that profit from large moves in either direction; traders typically buy PTCT straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
PTCT thesis for this straddle
The market-implied 1-standard-deviation range for PTCT extends from approximately $62.25 on the downside to $81.21 on the upside. A PTCT long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current PTCT IV rank near 18.56% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PTCT at 46.10%. As a Healthcare name, PTCT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PTCT-specific events.
PTCT straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PTCT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PTCT alongside the broader basket even when PTCT-specific fundamentals are unchanged. Always rebuild the position from current PTCT chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on PTCT?
- A straddle on PTCT is the straddle strategy applied to PTCT (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With PTCT stock trading near $71.73, the strikes shown on this page are snapped to the nearest listed PTCT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are PTCT straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the PTCT straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 46.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PTCT straddle?
- The breakeven for the PTCT straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PTCT market-implied 1-standard-deviation expected move is approximately 13.22%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on PTCT?
- Straddles on PTCT are pure-volatility plays that profit from large moves in either direction; traders typically buy PTCT straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current PTCT implied volatility affect this straddle?
- PTCT ATM IV is at 46.10% with IV rank near 18.56%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.